Group One Trading
TXG icon

Group One Trading’s 10x Genomics TXG Stock Holding History

Group One Trading’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$395K Buy
+10,300
New +$270K ﹤0.01% 3711
2026
Q1 		– Sell
-300
Closed -$4.89K – 8793
2025
Q4 		$4.89K Sell
300
-900
-75% -$13.6K ﹤0.01% 7192
2025
Q3 		$14K Sell
1,200
-7,800
-87% -$102K ﹤0.01% 6957
2025
Q2 		$104K Buy
9,000
+800
+10% +$7.29K ﹤0.01% 4924
2025
Q1 		$71.6K Buy
8,200
+5,800
+242% +$73.1K ﹤0.01% 4873
2024
Q4 		$34.5K Buy
2,400
+200
+9% +$3.16K ﹤0.01% 5338
2024
Q3 		$49.7K Sell
2,200
-9,700
-82% -$201K ﹤0.01% 4654
2024
Q2 		$231K Sell
11,900
-21,000
-64% -$550K ﹤0.01% 3267
2024
Q1 		$1.23M Buy
32,900
+32,800
+32,800% +$1.44M ﹤0.01% 1898
2023
Q4 		$5.6K Sell
100
-6,400
-98% -$278K ﹤0.01% 6461
2023
Q3 		$268K Sell
6,500
-100
-2% -$5.2K ﹤0.01% 3548
2023
Q2 		$369K Buy
6,600
+5,800
+725% +$314K ﹤0.01% 3336
2023
Q1 		$44.6K Buy
+800
New +$37.4K ﹤0.01% 4940
2022
Q4 		– Sell
-8,200
Closed -$234K – 8117
2022
Q3 		$234K Hold
8,200
– – ﹤0.01% 3982
2022
Q2 		$371K Buy
+8,200
New +$425K ﹤0.01% 3693
2021
Q4 		– Sell
-1,500
Closed -$218K – 8865
2021
Q3 		$218K Sell
1,500
-700
-32% -$120K ﹤0.01% 5082
2021
Q2 		$431K Sell
2,200
-7,400
-77% -$1.34M ﹤0.01% 4378
2021
Q1 		$1.74M Sell
9,600
-12,200
-56% -$2.11M ﹤0.01% 2626
2020
Q4 		$3.09M Buy
21,800
+14,700
+207% +$2.13M 0.01% 1675
2020
Q3 		$885K Sell
7,100
-2,300
-24% -$241K ﹤0.01% 2318
2020
Q2 		$840K Hold
9,400
– – ﹤0.01% 2194
2020
Q1 		$586K Buy
+9,400
New +$734K ﹤0.01% 1940

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading's TXG Position: Q2 2026 in Review

Group One Trading sold out of 10x Genomics (TXG) in Q2 2026, closing a stake of 3,843 shares — an estimated $101K sold.

Group One Trading first reported a position in TXG in Q4 2019 and held it in 11 quarters. The position peaked at $1.31M in Q1 2024. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Group One Trading reported no remaining 10x Genomics position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 3,843 10x Genomics shares in Q2 2026, an estimated $101K.
  • Group One Trading first reported a position in 10x Genomics in Q4 2019 and held it in 11 quarters.
  • Group One Trading's 10x Genomics position peaked at $1.31M in Q1 2024.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.